i would be far richer if i didn't have to pay for healthcare of mooching leafs and europoors.
>>62799175amerifats are paying my healthcare?
>>62799175Reminder that all americans believe they don't have healthcare because "they're paying for other country's healthcare" whereas they actually spend more on their own taxpayer funded healthcare than any other country does and their real problem is their healthcare system is a complete jewish ripoff
>>62799195Looks like.
>>62799224yes, we pay full cost for meds which get subsidized to the developing world (canada and europe)
>>62799277You simply pay for a giant parasitic medical insurance industry to exist and for doctors to be paid far too much. It doesn't benefit any other country that you do this. European countries have their own R&D. US costs are high because the US healthcare and insurance system allow them to be high.
>>62799296if nobody was paying full price the drugs would never have been invented. its an extremely expensive industry. you think GLP R&D would have become a strategy if european pricing structure was their only revenue source? lmao
>>62799307The basic GLP1 R&D was government funded, which is how it works with almost all drugs.Hardly any of the "extra cost" of US healthcare has anything to do with drug development. You're just being ripped off.
>>62799324https://pmc.ncbi.nlm.nih.gov/articles/PMC11214120/>The estimated mean cost of developing a new drug was approximately $172.7 million (2018 dollars) (range, $72.5 million for genitourinary to $297.2 million for pain and anesthesia), inclusive of postmarketing studies. The cost increased to $515.8 million when cost of failures was included. When the costs of failures and capital were included, the mean expected capitalized cost of drug development increased to $879.3 million (range, $378.7 million for anti-infectives to $1756.2 million for pain and anesthesia); results varied widely by therapeutic class. The pharmaceutical industry as a whole experienced a decline of 15.6% in sales but increased R&D intensity from 11.9% to 17.7% from 2008 to 2019. By contrast, R&D intensity of large pharmaceutical companies increased from 16.6% to 19.3%, whereas sales increased by 10.0% (from $380.0 to $418.0 billion) over the same 2008 to 2019 period, even though the cost of drug development remained relatively stable or may have even decreased.
>>62799328Why do you think that disproves my point, when it doesn't? Most basic R&D is government funded, pharma sponsors later phase trials. It's also a tiny drop in the ocean compared to the waste of money US healthcare is.
